Table 2.

Diagnostic criteria for primary diseases

SAIDs-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Had excessive systemic inflammation, leading to recurrent fever, rashes, increased C-reactive protein  and erythrocyte sedimentation rate, and IL-6 overproduction.

  • 3. No evidence of infection, tumor, or specific antibody involvement.

 
CAEBV-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Infectious mononucleosis-like symptoms persist or recurrent >3 mo.

  • 3. Evidence of EBV infection.

    • • Increased EBV-DNA copy numbers (>500 copies/L) in the peripheral blood and plasma (cell-free).

    • • Anti-EBV serological pattern indicated EBV reactivation from a previous infection: positive EBV nuclear antigen-IgG and EBV capsid antigen-IgG antibodies with high avidity.

    • • EBV-EBV encoded RNAs in situ hybridization was positive in the affected tissues.

  • 4. Lymph node or bone marrow pathologic biopsy suggests EBV-positive lymphoproliferative disease and exclusion of other possible diagnoses: known immunodeficiency and malignancy.

 
EBV-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Evidence of EBV infection.

    • • Increased EBV-DNA copy numbers (>500 copies/L) in the peripheral blood and plasma (cell-free).

    • • Anti-EBV serological pattern indicated primary or previous EBV infection.

  • 3. CAEBV was excluded.

 
SAIDs-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Had excessive systemic inflammation, leading to recurrent fever, rashes, increased C-reactive protein  and erythrocyte sedimentation rate, and IL-6 overproduction.

  • 3. No evidence of infection, tumor, or specific antibody involvement.

 
CAEBV-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Infectious mononucleosis-like symptoms persist or recurrent >3 mo.

  • 3. Evidence of EBV infection.

    • • Increased EBV-DNA copy numbers (>500 copies/L) in the peripheral blood and plasma (cell-free).

    • • Anti-EBV serological pattern indicated EBV reactivation from a previous infection: positive EBV nuclear antigen-IgG and EBV capsid antigen-IgG antibodies with high avidity.

    • • EBV-EBV encoded RNAs in situ hybridization was positive in the affected tissues.

  • 4. Lymph node or bone marrow pathologic biopsy suggests EBV-positive lymphoproliferative disease and exclusion of other possible diagnoses: known immunodeficiency and malignancy.

 
EBV-HLH: meet all the following criteria:
  • 1. Meet the HLH diagnosis criteria.

  • 2. Evidence of EBV infection.

    • • Increased EBV-DNA copy numbers (>500 copies/L) in the peripheral blood and plasma (cell-free).

    • • Anti-EBV serological pattern indicated primary or previous EBV infection.

  • 3. CAEBV was excluded.

 
Close Modal

or Create an Account

Close Modal
Close Modal